Paper · 2026 · Open access

ALZHEIMER'S DISEASE: EMERGING DRUG THERAPIES

Mr. Hosanna Jacob Ezekiel. B, Dr. M.K. Sundar sri, Dr. M. Kalaiarasan

Zenodo (CERN European Organization for Nuclear Research) · Published 6 July 2026 · DOI 10.5281/zenodo.21221533

Read the free full textCite this paper

In brief

“ALZHEIMER'S DISEASE: EMERGING DRUG THERAPIES” is a 2026 paper by Mr. Hosanna Jacob Ezekiel. B, Dr. M.K. Sundar sri, Dr. M. Kalaiarasan, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).

Citations
0
Authors
1

Abstract

The Alzheimer's disease (AD) is a neurodegenerative disease and leading cause of dementia which involves progressive decline of cognitive function and behavioral disorders. The rising life expectancy and increase in elderly population have greatly increased the burden of AD on public health. Currently available treatment modalities, like cholinesterase inhibitors, N-methyl-D-aspartate (NMDA) receptor antagonists and anti-amyloid monoclonal antibodies offer relief from symptoms or delay in disease progression but lack efficacy in prevention of neurodegeneration. With the advancement of knowledge about the molecular mechanism of disease process, a large number of therapeutic targets have been identified, namely amyloid beta, tau protein, neuroinflammation, oxidative stress, mitochondrial dysfunction, synapse loss, and insulin resistance. Modern treatment strategies include gene therapy, RNA based therapeutics, stem cell therapy, immunotherapy, personalized medicine, repurposed drugs and novel drug delivery systems. More research and clinical trials will lead to development of safer and efficacious therapies to manage the disease process and alleviate the burden of the disease. Keywords: Alzheimer's disease; Neurodegeneration; Amyloid-β; Tau protein; Monoclonal antibodies; Disease-modifying therapies; Gene therapy; RNA therapeutics; Stem cell therapy; Precision medicine.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kalaiarasan, M. H. J. E. B. D. M. S. S. D. M. (2026). ALZHEIMER'S DISEASE: EMERGING DRUG THERAPIES. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.21221533

MLA 9

Kalaiarasan, Mr. Hosanna Jacob Ezekiel. B, Dr. M.K. Sundar sri, Dr. M. “ALZHEIMER'S DISEASE: EMERGING DRUG THERAPIES.” Zenodo (CERN European Organization for Nuclear Research), 2026. https://doi.org/10.5281/zenodo.21221533.

Chicago

Kalaiarasan, Mr. Hosanna Jacob Ezekiel. B, Dr. M.K. Sundar sri, Dr. M. 2026. “ALZHEIMER'S DISEASE: EMERGING DRUG THERAPIES.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.21221533.

Harvard

Kalaiarasan, M. H. J. E. B. D. M. S. S. D. M. (2026) ‘ALZHEIMER'S DISEASE: EMERGING DRUG THERAPIES’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.21221533.

IEEE

M. H. J. E. B. D. M. S. S. D. M. Kalaiarasan, “ALZHEIMER'S DISEASE: EMERGING DRUG THERAPIES,” Zenodo (CERN European Organization for Nuclear Research), 2026, doi: 10.5281/zenodo.21221533.

BibTeX

@article{kalaiarasan2026alzheimer,
  title     = {{ALZHEIMER'S DISEASE: EMERGING DRUG THERAPIES}},
  author    = {Kalaiarasan, Mr. Hosanna Jacob Ezekiel. B, Dr. M.K. Sundar sri, Dr. M.},
  journal   = {Zenodo (CERN European Organization for Nuclear Research)},
  year      = {2026},
  doi       = {10.5281/zenodo.21221533},
  url       = {https://doi.org/10.5281/zenodo.21221533}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • Alzheimer's disease
  • neurodegeneration
  • amyloid-beta
  • tau protein
  • disease-modifying therapy
  • cholinesterase inhibitors
  • NMDA receptor antagonists
  • anti-amyloid monoclonal antibodies

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Kalaiarasan, M. H. J. E. B. D. M. S. S. D. M. (2026). ALZHEIMER'S DISEASE: EMERGING DRUG THERAPIES. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.21221533

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).

Who wrote this paper?

Mr. Hosanna Jacob Ezekiel. B, Dr. M.K. Sundar sri, Dr. M. Kalaiarasan.

What is the DOI of this paper?

10.5281/zenodo.21221533. The permanent link is https://doi.org/10.5281/zenodo.21221533.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.